Thus, while serum IFNγ has been recently shown to inversely correlate with tumor progression and metastasis [62], the data presented here show a broader picture of the mechanics through which IFNγ influences outcomes, by regulation of the immune cell types in the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.